March 18, 2021 Lower mid-market-focused private equity firm The Riverside Company has agreed to sell airline and utilities critical infrastructure software provider Arcos to Vista Equity Partners.
AltAssets has been serving the global private equity industry for over a decade and has become established as a trusted source of independent news and views on the industry by thousands of professionals worldwide.
Press release content from Business Wire. The AP news staff was not involved in its creation.
FEops Announces 2.000 Patients Modelled With FEops HEARTguide™
February 1, 2021 GMT
GENT, Belgium (BUSINESS WIRE) Feb 1, 2021
FEops, a digital health leader in personalized predictive planning for structural heart interventions, is proud to announce having modeled 2000 patients with FEops HEARTguide™ for the pre-operative planning of structural heart interventions.
FEops HEARTguide™ is currently commercially available in the European Union, Canada and Australia for its TAVI and LAAo workflows and offers a one-in-its-kind procedure planning environment for structural heart interventions that provides physicians unique insights to evaluate device sizing and positioning pre-operatively using novel computational modeling and simulation technology.
Posted on 418
FEops, a digital health leader in personalized predictive planning for structural heart interventions, is proud to announce having modeled 2000 patients with FEops HEARTguide™ for the pre-operative planning of structural heart interventions.
FEops HEARTguide™ is currently commercially available in the European Union, Canada and Australia for its TAVI and LAAo workflows and offers a one-in-its-kind procedure planning environment for structural heart interventions that provides physicians unique insights to evaluate device sizing and positioning pre-operatively using novel computational modeling and simulation technology.
“Only 2 years after the launch of FEops HEARTguide™, we are thrilled to see the accelerated clinical adoption of FEops HEARTguide™ with over 2.000 patients’ cases modeled. This significant milestone is reached thanks to the physicians who use our technology on regular basis, ou
Press release content from Business Wire. The AP news staff was not involved in its creation.
Extended FEops HEARTguide™ Offering Now Available
December 18, 2020 GMT
GENT, Belgium (BUSINESS WIRE) Dec 18, 2020
FEops, a digital health leader in personalized predictive planning for structural heart interventions, is proud to announce the new release of
FEops HEARTguide TM. This includes the full range of the Boston Scientific WATCHMAN FLX™ devices, enhanced visualization for the prediction of paravalvular leak (PVL) and conduction abnormalities (CA) for the transcatheter aortic valve implantation (TAVI) workflow. This product will also offer a faster turnaround for the left atrial appendage occlusion (LAAo) workflow.
Extended FEops HEARTguide Offering Now Available
FEops HEARTguide
TM. This includes the full range of the Boston Scientific WATCHMAN FLX devices, enhanced visualization for the prediction of paravalvular leak (PVL) and conduction abnormalities (CA) for the transcatheter aortic valve implantation (TAVI) workflow. This product will also offer a faster turnaround for the left atrial appendage occlusion (LAAo) workflow.
FEops HEARTguide is commercially available in the European Union, Canada and Australia for the TAVI and LAAo workflows and offers a one-in-its-kind procedure planning environment for structural heart interventions that provides physicians unique insights to evaluate device sizing and positioning pre-operatively using novel computational modeling and simulation technology.